HUT40427A - Process for producing 1,3,4-oxa- and -thia-diazol derivatives and pharmaceutical compositions containing them - Google Patents

Process for producing 1,3,4-oxa- and -thia-diazol derivatives and pharmaceutical compositions containing them

Info

Publication number
HUT40427A
HUT40427A HU854271A HU427185A HUT40427A HU T40427 A HUT40427 A HU T40427A HU 854271 A HU854271 A HU 854271A HU 427185 A HU427185 A HU 427185A HU T40427 A HUT40427 A HU T40427A
Authority
HU
Hungary
Prior art keywords
thia
oxa
producing
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU854271A
Other languages
English (en)
Other versions
HU194197B (en
Inventor
Kurt Wegner
Helmut Schickaneder
Istvan Szelenyi
Irene Kramer
Helmut Schunack
Kurt M Ahrens
Original Assignee
Heumann Ludwig & Co Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heumann Ludwig & Co Gmbh filed Critical Heumann Ludwig & Co Gmbh
Publication of HUT40427A publication Critical patent/HUT40427A/hu
Publication of HU194197B publication Critical patent/HU194197B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/1131,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
HU854271A 1984-11-09 1985-11-06 Process for producing 1,3,4-oxa- and -thia-diazol derivatives and pharmaceutical compositions containing them HU194197B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843441086 DE3441086A1 (de) 1984-11-09 1984-11-09 3,4-diazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
HUT40427A true HUT40427A (en) 1986-12-28
HU194197B HU194197B (en) 1988-01-28

Family

ID=6249961

Family Applications (1)

Application Number Title Priority Date Filing Date
HU854271A HU194197B (en) 1984-11-09 1985-11-06 Process for producing 1,3,4-oxa- and -thia-diazol derivatives and pharmaceutical compositions containing them

Country Status (15)

Country Link
US (1) US4727081A (hu)
EP (1) EP0180754A3 (hu)
JP (1) JPS61115074A (hu)
KR (1) KR860004040A (hu)
AU (1) AU575441B2 (hu)
DE (1) DE3441086A1 (hu)
DK (1) DK512185A (hu)
ES (4) ES8609315A1 (hu)
GR (1) GR852687B (hu)
HU (1) HU194197B (hu)
IL (1) IL76818A (hu)
NZ (1) NZ214097A (hu)
PT (1) PT81427B (hu)
YU (1) YU173585A (hu)
ZA (1) ZA858194B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3513184A1 (de) * 1985-04-12 1986-10-16 Ludwig Heumann & Co GmbH, 8500 Nürnberg 1,3,4-thiadiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CN101863852B (zh) * 2010-06-29 2011-09-21 沈阳航空航天大学 含1,3,4-噁二唑杂环结构芳香二元胺及其制备方法
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA815964B (en) * 1980-08-27 1983-04-27 Glaxo Group Ltd Heterocyclic derivatives
JPS59196879A (ja) * 1983-04-08 1984-11-08 Wakamoto Pharmaceut Co Ltd 新規な1,3,4−チアジアゾ−ル誘導体
JPS6067474A (ja) * 1983-09-24 1985-04-17 Wakamoto Pharmaceut Co Ltd 新規な1,3,4−チアジアゾ−ル誘導体及びそれを有効成分とする抗潰瘍剤
JPS60255756A (ja) * 1984-06-01 1985-12-17 Ikeda Mohandou:Kk アミノアルキルフエノキシ誘導体

Also Published As

Publication number Publication date
EP0180754A2 (de) 1986-05-14
PT81427B (de) 1987-04-09
ES548289A0 (es) 1986-09-01
ES554601A0 (es) 1987-04-16
ES8704488A1 (es) 1987-04-16
ES554602A0 (es) 1987-04-16
HU194197B (en) 1988-01-28
US4727081A (en) 1988-02-23
EP0180754A3 (de) 1987-02-25
IL76818A0 (en) 1986-02-28
KR860004040A (ko) 1986-06-16
ZA858194B (en) 1986-06-25
DK512185D0 (da) 1985-11-06
GR852687B (hu) 1986-03-11
ES8704489A1 (es) 1987-04-16
IL76818A (en) 1990-06-10
AU575441B2 (en) 1988-07-28
ES554603A0 (es) 1987-04-16
ES8609315A1 (es) 1986-09-01
DE3441086A1 (de) 1986-05-15
AU4933385A (en) 1986-05-15
ES8704487A1 (es) 1987-04-16
YU173585A (en) 1988-04-30
DK512185A (da) 1986-05-10
PT81427A (de) 1985-12-01
JPS61115074A (ja) 1986-06-02
NZ214097A (en) 1988-08-30

Similar Documents

Publication Publication Date Title
HUT41790A (en) Process for producing beta-amino-purine derivatives and pharmaceutical compositions containing them
HUT44512A (en) Process for producing bensyl derivatives and pharmaceutical compositions containing them
HUT48624A (en) Process for producing 6-benzoxazinyl- and 6-benzothiazinyl-2,3,4,5-tetrahydropyridazin-3-ones and pharmaceutical compositions comprising such compounds
HUT48248A (en) Process for producing 3,7-diazabicyclo/3,3,1/-nonan derivatives and pharmaceutical compositions containing them
HUT42478A (en) Process for producing gamma-carboline derivatives and pharmaceutical compositions containing them
HUT41035A (en) Process for producing cepheme derivatives and pharmaceutical compositions containing them
HUT41753A (en) Process for producing 1,4-benzothiazine derivatives and pharmaceutical compositions containing them
HUT41392A (en) Process for producing new imidazolyl-alkyl-guanidine derivatives and pharmaceutical compositions containing them
HUT46303A (en) Process for producing 3-/omega-/3,5-di-/tetrabutil/-4-hydroxy-phenyl/-alkanoyl/-pyrroles andtheyr deoxy-analogues and pharmaceutical compositions containing them
HUT43820A (en) Process for producing n-(-2-((-2-hydroxy-phenyl-)(-phenyl-)-methylene-aminosquare )-ethyl-)-acetamide derivatives and pharmaceutical compositions containing them
HUT37148A (en) Process for producing 8 alpha-acyl-amino-ergoline derivatives and pharmaceutical compositions containing them
HUT41784A (en) Process for producing 1,8-naphtiridine derivatives and pharmaceutical compositions containing them as active agents
HUT38367A (en) Process for producing epoxy-steroides and pharmaceutical compositions containing them
HUT44524A (en) Process for producing 1,3-thiazolyl- or 1,3,4-thiadiazolyl- derivatives and pharmaceutical compositions containing them
HUT41984A (en) Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
HUT47096A (en) Process for producing 1,2-dithiol-3-thion derivatives and pharmaceutical compositions containing them as active components
HUT44527A (en) Process for producing new alkylene-diamine derivatives and pharmaceutical compositions containing them
HUT46030A (en) Process for producing citostatic antracyclin-glycoside derivatives and pharmaceutical compositions containing them
HUT37632A (en) Process for producing new delta 4 above- and delta 5 above-androstene derivatives and pharmaceutical compositions containing them
ZA848303B (en) 1,2-dithiolan derivatives,process for their production,pharmaceutical compositions containing them and their use
HUT37423A (en) Process for preparing 1,3-dioxolanyl derivatives and pharmaceutical compositions containing thereof
HUT39438A (en) Process for producing naphtoxazine derivatives and pharmaceutical compositions containing them
HUT37746A (en) Process for producing cycloalkane-indene-carboximide-amide derivatives and pharmaceutical compositions containing them
MY8600467A (en) 3,3-dialkyl-and 3,3-alkylene-indoline derivatives, process for their production and pharmaceutical compositions comprising them
HUT37155A (en) Process for producing n-acylized 1-lakyl-amino-1-deoxy-ketoze derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee